Skip to main content
Upsala Journal of Medical Sciences logoLink to Upsala Journal of Medical Sciences
. 2025 May 16;130:10.48101/ujms.v130.11924. doi: 10.48101/ujms.v130.11924

Associations of lower values of peak oxygen uptake and handgrip strength with a smaller liver volume

Muhammad Naeem a,b,, Marcello Ricardo Paulista Markus c,d,e, Martin Bahls c,e, Mohammed Mousa a, Marcus Dörr c,e, Jens-Peter Kühn f, Robin Bülow g, Stephan B Felix c,e, Giovanni Targher h,i, Beate Stubbe c, Ralf Ewert c, Henry Völzke a,b,j, Till Ittermann a,e
PMCID: PMC12138976  PMID: 40474965

Abstract

Background and aims

The associations between physical fitness markers and liver volume in the general population are unclear. We investigated the associations of peak oxygen uptake (VO2peak)and handgrip strength with liver volume in a general population sample.

Methods and results

Data were taken from 1,531 German adults (51.3% women), aged 20 to 88 years, from two cohorts of the population-based Study of Health in Pomerania (SHIP-START-2 and SHIP-TREND-0). We analysed cross-sectional associations of VO2peak and handgrip strength with liver volume derived from magnetic resonance imaging (MRI) by using multivariable linear regression models. These models were adjusted for age, sex, body fat mass, pre-existing type 2 diabetes, daily alcohol consumption, smoking status, and use of hypoglycaemic or antihypertensive medications. We observed significant associations of lower VO2peak and handgrip strength with a smaller liver volume in the whole population, as well as in both men and women. In the whole population, a 1 L/min lower VO2peak was associated with a 0.15 cm3 (95% confidence interval [CI]: 0.11 to 0.19; P < 0.0001) smaller liver volume for both sexes together. Similarly, a 1 kg lower handgrip strength was associated with a 7.05 cm3 (95% CI: 4.87 to 9.23; P < 0.001) smaller liver volume in the whole population.

Conclusion

Our results derived from a large community-based sample showed that lower values of VO2peak and handgrip strength were associated with a smaller liver volume. These results might explain the possible negative effects of sedentary lifestyle on liver volume – the sedentary liver.

KEYWORDS: Peak oxygen uptake, handgrip strength, liver volume

Introduction

Physical fitness is considered to be a significant predictor of mortality and morbidity (1), and can be separated in cardiorespiratory fitness and muscular fitness (2). While cardiorespiratory fitness refers to the ability of the cardiovascular and respiratory systems to afford constant oxygen and blood supply to skeletal muscles during exercise (3), muscular fitness indicates the muscular mass and the physical strength, power, and endurance (4). Cardiorespiratory fitness is measured by peak oxygen uptake (VO2peak) through cardiopulmonary exercise test (5), while muscular fitness can be accurately measured by handgrip strength (6, 7). To date, VO2peak is considered the gold standard method for the estimation of cardiorespiratory fitness and the better predictor of cardiovascular mortality and morbidity (8). Lower muscular strength is a predictor of ageing and overall poor health outcome (9). The capacity of muscular strength and power decreases with ageing and is associated with physical disability and mortality (10). While VO2peak may predict the risk for cardiovascular events and mortality better than handgrip strength (11), handgrip strength is suggested to be a simple and independent prognostic marker for cardiovascular and all-cause mortality in the population-based on data taken from 17 countries (12).

Sedentary behaviour is increasing in the general population of Western countries, and is an established risk factor for cardiovascular disease and all-cause mortality (13). Physical inactivity is also a risk factor for all types of advanced liver diseases and particularly for hepatic steatosis (14). A recent meta-analysis showed that an increase in VO2peak and a decrease in body weight are both associated with a decrease in liver fat content as assessed by either magnetic resonance imaging (MRI) or proton magnetic resonance spectroscopy (15). Similarly, lower handgrip strength is associated with higher serum liver enzyme levels and higher risk of liver diseases in adolescents, especially in boys (16). Recent cross-sectional studies published by our group (1720) showed that low values of cardiorespiratory (17, 18, 20) and muscular fitness (19) were significantly associated with a smaller and stiffer heart, which we called ‘the sedentary heart’. Previous studies investigated associations of cardiorespiratory fitness (21) or handgrip strength (22) with hepatic steatosis, but there is currently a lack of published studies investigating the associations of cardiorespiratory fitness or handgrip strength with MRI-assessed liver volume. A recent study (23) from our group showed a nearly three-fold higher risk of all-cause mortality in individuals with a larger liver volume independently of known metabolic risk factors. In a similar way, we aimed to investigate whether markers of cardiorespiratory fitness and muscular fitness are associated with liver volume. Therefore, we examined the associations of cardiorespiratory fitness and muscular fitness determined by VO2peak and handgrip strength with MRI-assessed liver volume in a population-based cohort from Germany.

Materials and methods

Study population

The data were obtained from the Study of Health in Pomerania (SHIP), a population-based study conducted in Northeast Germany. The study design and recruitment strategy have been described elsewhere in more detail (24). For the current analysis, we used data from participants of the SHIP-START-2 and SHIP-TREND-0 (2008–2012). From the 6,753 adult individuals participating in the SHIP-START-2 or SHIP-TREND-0, we used a subsample of 2,793 subjects who were eligible and underwent a whole-body MRI. From this sample we excluded individuals with missing values in VO2peak (n = 571), liver volume (n = 644), handgrip strength (n = 17), body fat mass (n = 22), alcohol consumption (n = 7), and use of antihypertensive medication (n = 1). Thus, the final sample of participants consisted of 1,531 subjects (786 women; 51.3%) aged 21 to 88 years (Figure 1).

Figure 1.

Figure 1

Flow chart for the study participants.

All participants have given written informed consent to participate in the study. The study conformed to the ethical guidelines of the Declaration of Helsinki as reflected in a priori approval by the local ethics committee of the University of Greifswald.

Cardiopulmonary exercise testing and gas exchange variables

A symptom-limited exercise test using a calibrated electromagnetically braked cycle ergometer (Ergoselect 100, Ergoline, Germany) was performed in all participants according to a modified Jones protocol. Oxygen uptake (VO2) was analysed breath-by-breath averaged over 10-sec intervals using the Oxycon Pro system (Jaeger/Viasys Healthcare; Hoechberg, Germany), together with a Rudolph’s mask, which was recalibrated before each test. VO2peak in L/min was defined as the highest 10-sec average of absolute VO2 during late exercise or early recovery (25).

Handgrip strength assessment

Handgrip strength was measured one time in each hand for all the participants using a hand-grip dynamometer (Smedley’s Dynamometer, Scandidact, Odder, Denmark), with the upper arm being held against the trunk and the elbow in a 90-degree flexion while standing. Participants were instructed to squeeze the handle as hard as possible for 3 sec, and the maximum contractile force in kilogram (kg) was recorded. The highest value obtained from the left and right handgrip strength measurements was used in the present analyses (19).

Bioelectrical impedance analysis

Fat-free mass and fat mass were measured by bioelectrical impedance analysis using a multifrequency Nutriguard-M device (Data Input, Pöcking, Germany) and the NUTRI4 software (Data Input, Pöcking, Germany) (26).

Magnetic resonance imaging

A liver MRI was performed in all the participants using a 1.5-Tesla MRI system (Magnetom Avanto, software version VB15; Siemens Healthineers Erlangen, Germany) with a 12-channel phased-array surface coil 25. Liver fat content was assessed with offline reconstructions of a proton density fat fraction (PDFF) map. Mean PDFF values were determined at operator-defined regions of interest placed at the centre of the liver, by using Osirix (v3.8.1; Pixmec Sarl, Bernex, Switzerland). Presence of hepatic steatosis was defined as MRI-PDFF ≥5.1% (27).

Assessment of liver volume

Assessment of liver volume was performed by a calculation of volume indices. For this reason, measurement of liver diameters was performed using the software Osirix (version 4.6; Pixameo, Bernex, Switzerland) by a trained observer who was blind to clinical and biochemical data of participants. In each participant, MRI-assessed liver diameters were measured in mid-clavicular line in the following three orientations: anterior-posterior (1); lateral-medial (2); and cranio-caudal (6). Thereafter, the volume index and estimated liver volume was calculated using the following formula: liver volume = (A × B × C)/2.6 (28).

Statistical analysis

Continuous data were expressed as medians (with 25th percentiles and 75th percentiles) and categorical variables as absolute and relative percentages by quartiles of VO2peak and sex. Multivariable linear regression models were used for testing the associations of VO2peak and handgrip strength with liver volume. These regression models were adjusted for age, sex (except when stratified by sex), body fat mass, pre-existing type 2 diabetes, daily alcohol consumption, smoking status, and use of hypoglycaemic or antihypertensive medications (Figure 2).

Figure 2.

Figure 2

Adjusted* regression line showing the associations between peak oxygen uptake (VO2peak) and MRI-assessed liver volume in both pooled sex analyses (n = 1,531) and stratified by sex (men = 745; women = 786). *Linear regression was adjusted for age, sex (except when stratified by sex), body fat mass, pre-existing type 2 diabetes, daily alcohol consumption, and smoking status use of hypoglycaemic or antihypertensive medications. NB: The association between VO2peak and liver volume is presented with a reverse x-axis to make the interpretation of results more intuitive.

A P < 0.05 was considered to be statistically significant. All statistical analyses were performed using Stata 14.2 (Stata Corporation, College Station, TX, USA).

Results

Table 1 and Table 2 shows descriptive data of the study participants stratified by VO2peak quartiles and sex. In both men and women, the median VO2peak, handgrip strength and total body weight increased from the first to the fourth quartile of VO2peak. Men and women in the first VO2peak quartile were older, had higher systolic blood pressure, and were more likely to have hypertension and known diabetes with a more frequent use of hypertensive, glucose-lowering, and lipid-lowering medications than subjects belonging to other VO2peak quartiles. Men in the VO2peak fourth quartile were more likely to be (former and current) smoker compared to men in the other quartiles.

Table 1.

Characteristics of study sample stratified by VO2peak quartiles in men (n = 745).

Parameter(s) First quartile (n = 187) Second quartile (n = 186) Third quartile (n = 186) Fourth quartile (n = 186) P
VO2peak (L/min) 1.76 (1.56; 1.90) 2.20 (2.10; 2.35) 2.63 (2.53; 2.75) 3.16 (3.00; 3.41) < 0.001
Handgrip strength (kg) 41.0 (36.0; 47.0) 47.0 (41.5; 52.0) 49.5 (44.5; 54.0) 52.0 (47.0; 57.5) < 0.001
Liver volume (cm3) 1.41 (1.25; 1.63) 1.55(1.35; 1.74) 1.65(1.40; 1.91) 1.69 (1.50; 1.91) < 0.001
Age (years) 65.5 (56.0; 72.0) 55.0 (46.0; 64.0) 49.5 (40.0; 57.0) 42.0 (36.0; 49.0) < 0.001
Height (cm) 173 (170; 178) 175 (171; 180) 178 (174; 181) 181 (177; 185) < 0.001
Waist circumference (cm) 97.0 (90.0; 104) 95.5 (89.5; 104) 94.5 (87.5; 103) 91.0 (84.0; 100) < 0.001
Waist-to-height ratio 0.56 (0.52;60.0) 0.55 (0.51; 0.59) 0.53 (0.50; 0.58) 0.50 (0.46; 0.56) < 0.001
Body mass index (kg/m2) 27.5 (25.7; 30.1) 27.8 (25.9; 30.5) 27.8 (25.5; 30.5) 27.0 (24.8; 30.2) 0.154
Body fat-free mass (kg) 63.3 (58.2; 68.4) 65.4(61.0; 71.0) 67.0 (62.0; 72.3) 69.2 (64.1; 74.6) < 0.001
Body fat mass (kg) 20.0 (16.0; 24.6) 20.2 (16.5; 25.1) 20.4 (16.0; 25.0) 19.4 (15.1; 25.5) 0.796
Total body weight (kg) 82.0 (75.3; 92.4) 86.2 (78.1; 96.0) 87.1 (80.0; 96.6) 88.7 (80.2; 99.2) < 0.001
Systolic blood pressure (mmHg) 135 (125; 146) 134 (124; 146) 134 (124; 144) 128 (121; 138) < 0.001
Diastolic blood pressure (mmHg) 79 (72; 86) 81 (75; 88) 82 (76; 89) 78 (73; 84) < 0.001
Hypertension (%) 64.5 57.4 52.3 31.5 < 0.001
Antihypertensive medications (%) 42.6 32.3 26.1 13.2 <0.001
Glycated haemoglobin (%) 5.40 (5.20; 5.80) 5.30 (5.00; 5.70) 5.30 (5.10; 5.60) 5.20 (4.90; 5.40) < 0.001
Pre-existing type 2 diabetes (%) 17.6 10.7 4.30 1.08 < 0.001
Hypoglycaemic medications (%) 12.8 8.60 3.23 0.54 < 0.001
LDL-cholesterol (mmol/L) 3.36 (2.84; 3.87) 3.46 (2.88; 4.01) 3.48 (3.01; 4.04) 3.33 (2.67; 3.89) 0.008
HDL-cholesterol (mmol/L) 1.24 (1.05; 1.45) 1.26 (1.08; 1.49) 1.28 (1.07; 1.48) 1.28 (1.09; 1.55) 0.216
Lipid lowering medications (%) 21.6 16.9 8.09 2.63 < 0.001
Smoking (%)
 Never 27.3 28.1 32.6 39.7 0.067
 Former 46.7 46.2 45.5 41.3
 Current 26.0 25.6 22.0 19.0
Alcohol consumption (g/day) 6.82 (1.88; 16.9) 9.22 (3.43; 19.7) 9.83 (3.74; 19.7) 9.06 (3.07; 19.3) 0.058
Sedentary lifestyle (%) 36.5 31.0 31.4 19.0 < 0.001

Table 2.

Characteristics of study sample stratified by VO2peak quartiles in women (n = 786).

Parameter(s) First quartile (n = 197) Second quartile (n = 196) Third quartile (n = 197) Fourth quartile (n = 196) P
VO2peak (L/min) 1.17 (1.05; 1.27) 1.46 (1.40; 1.50) 1.68 (1.62; 1.75) 2.00 (1.90; 2.20) < 0.001
Handgrip strength (kg) 25.0 (21.5; 28.5) 27.0 (23.5; 31.0) 28.0 (25.0; 31.0) 31.0 (28.0; 35.0) < 0.001
Liver volume (cm3) 1.20 (1.05; 1.36) 1.24 (1.22; 1.43) 1.31 (1.18; 1.48) 1.45 (1.30; 1.64) < 0.001
Age (years) 62.0 (52.0; 70.0) 56.0 (46.0; 62.0) 49.0 (42.0; 59.0) 44.0 (39.0; 52.0) < 0.001
Height (cm) 160 (157; 165) 163 (158; 167) 164 (160; 169) 167 (164; 171) < 0.001
Waist circumference (cm) 82.3 (75.0; 91.5) 81.4 (74.4; 91.8) 81.5 (74.7; 92.4) 82.0 (73.9; 92.4) 0.878
Waist-to-height ratio 0.51 (0.46; 0.57) 0.50 (0.46; 0.57) 0.50 (0.45; 0.56) 0.49 (0.49; 0.56) 0.074
Body mass index (kg/m2) 26.0 (23.0; 29.3) 26.1 (23.5; 30.0) 25.9 (23.3; 30.2) 26.9 (24.0; 31.0) 0.015
Body fat-free mass (kg) 45.0 (41.8; 47.6) 45.5 (42.7; 49.0) 47.4 (44.3; 50.5) 50.3 (47.1; 54.6) < 0.001
Body fat mass (kg) 23.0 (16.5; 28.5) 23.4 (18.0; 30.0) 23.4 (18.2; 29.7) 26.0 (19.5; 33.1) < 0.001
Total body weight (kg) 66.7 (60.0; 75.2) 68.5 (61.5; 78.1) 71.0 (64.0; 80.3) 76.0 (66.7; 86.6) < 0.001
Systolic blood pressure (mmHg) 125 (112; 137) 120 (110; 132) 117 (109; 129) 116 (108; 127) < 0.001
Diastolic blood pressure (mmHg) 73 (68; 81) 75 (69; 81) 75 (69; 81) 74 (69; 81) 0.442
Hypertension (%) 48.1 38.5 30.9 26.7 < 0.001
Antihypertensive medications (%) 35.6 28.4 24.2 21.7 < 0.002
Glycated haemoglobin (%) 5.30 (4.90; 5.60) 5.20 (4.90; 5.60) 5.20 (4.80; 5.50) 5.10 (4.80; 5.50) 0.004
Pre-existing type 2 diabetes (%) 9.64 8.67 5.58 3.57 0.026
Hypoglycaemic medications (%) 7.61 4.08 2.54 0.51 0.002
LDL-cholesterol (mmol/L) 3.48 (2.92; 4.08) 3.38 (2.78; 4.11) 3.23 (2.68; 3.87) 3.14 (2.48; 3.79) < 0.001
HDL-cholesterol (mmol/L) 1.61 (1.36; 1.91) 1.61 (1.36; 1.92) 1.60 (1.38; 1.80) 1,57 (1.32; 1.83) 0.238
Lipid lowering medications (%) 15.9 10.7 4.60 2.04 < 0.001
Smoking (%)
 Never 56.2 47.5 43.1 41.0 0.010
 Former 24.8 30.7 36.5 38.2
 Current 19.0 21.8 20.4 20.9
1.80 (0.17; 5.02) 2.56 (0.72; 5.22) 2.74 (0.72; 6.61) 2.90 (0.99; 6.52) < 0.001
31.4 28.8 24.2 18.1 0.003

Data are presented as medians (25th, 75th percentiles) for continuous data and absolute numbers or percentages for categorical data. Kruskal-Wallis test was used for continuous variables and chi- square tests for the categorical variables.

Reversal of the x-axis scale to run from maximum VO2peak and handgrip strength value to minimum

Sedentary lifestyle is significantly associated with lower values of both VO2peak and handgrip strength. The central effort of our study is to show the results of consecutively lower values of both VO2peak and handgrip strength on liver volume after adjusting for potential confounding factors. For such reason, all associations between VO2peak, and handgrip strength with liver volume are presented with a reverse x-axis to make the interpretation of results more intuitive.

Association between VO2peak and liver volume

Figure 2 shows the adjusted linear association between VO2peak and liver volume after adjustment for potential confounding factors. In multivariable adjusted regression analyses, we observed a significant association between lower VO2peak and smaller liver volume for both sexes together and also separately for men and women when stratified by sex. In detail, a 1 L/min lower VO2peak was associated with a 0.15 cm3 (95% confidence interval [CI]: 0.12 to 0.19; P < 0.001) lower liver volume for both sexes together. When stratified by sex, a 1 L/min lower VO2peak was associated with a 0.16 cm3 (0.11 to 0.21; P < 0.001) lower liver volume in men and a 0.17 cm3 (0.12 to 0.23; P < 0.001) in women, respectively (Table 3).

Table 3.

Sex-stratified associations of handgrip strength and VO2peak with liver volume.

Variables Men Women
ß (95% CI) P Adjusted R2 ß (95% CI) P Adjusted R2
Handgrip strength (kg) 7.73 (4.67; 10.8) 0.000 0.38 4.52 (0.97; 8.06) 0.01 0.42
VO2peak (L/min) 0.16 (0.11; 0.20) 0.000 0.40 0.17 (0.11; 0.23) 0.000 0.45

CI: Confidence intervals.

Linear regression was used by calculating beta coefficient with 95% CI and was adjusted for age, body fat mass, pre-existing type 2 diabetes, daily alcohol consumption and use of hypoglycaemic or antihypertensive medications.

ß (95% CI): beta-coefficient with 95% confidence intervals; VO2peak: peak oxygen uptake.

Association between handgrip strength and liver volume

There was a significant adjusted association between lower handgrip strength and smaller liver volume for both sexes and also separately for men and women when stratified by sex (Figure 3). A 1-kg lower handgrip strength was associated with a 7.28 cm3 (95% CI: 5.16 to 9.42; P < 0.001) lower liver volume for both sexes together. When stratified by sex, a 1 kg lower handgrip strength was associated with a 7.73 cm3 (4.67 to 10.8; P < 0.001) lower liver volume in men and a 4.52 cm3 (0.97 to 8.06; P = 0.01) in women, respectively (Table 3).

Figure 3.

Figure 3

Adjusted* regression line showing the associations between handgrip strength and MRI-assessed liver volume in both pooled sex analyses (n = 1,531) and stratified by sex (men = 745; women = 786). *Linear regression was adjusted for age, sex (except when stratified by sex), body fat mass, pre-existing type 2 diabetes, daily alcohol consumption, and use of hypoglycaemic or antihypertensive medications. NB: The association between handgrip strength and liver volume is presented with a reverse x-axis to make the interpretation of results more intuitive.

We standardised VO2peak and handgrip strength and investigated their associations with liver volume. A one standard deviation (SD) lower VO2peak was associated with a 0.32 cm3 (95% CI: 0.25 to 0.38) smaller liver volume while a one SD lower handgrip strength was associated with a 0.09 cm3 (95% CI: 0.06 to 0.11) smaller liver volume.

We further investigated the potential effect modifications of study cohort (SHIP-START-2 vs. SHIP-TREND-0) on the observed associations between VO2peak or handgrip strength with liver volume. In none of these subgroup analyses, we observed any significant interaction between the study cohort and the respective exposure on liver volume (P > 0.05). In sensitive analysis, we found that the fat-free mass (FFM) explains 55% variation in liver volume and 47% in VO2peak and handgrip strength.

Discussion

As far as we know, this is the first and largest population-based study investigating the associations of VO2peak and handgrip strength with MRI-assessed liver volume. In our cohort of 1,531 German middle-aged individuals, we found that lower values of VO2peak and handgrip strength were significantly associated with a smaller liver volume in the whole population as well as in men and women, separately. These associations remained statistically significant even after adjustment for potential confounding factors, such as age, sex (except when stratified by sex), body fat mass, pre-existing type 2 diabetes, daily alcohol consumption, smoking history, and current use of hypoglycaemic or antihypertensive medications.

The putative biological mechanisms underpinning our observed associations are not entirely clear, but a possible explanation might be a decrease in FFM following a sedentary lifestyle. A decrease in FFM might lead to a reduction in total blood and plasma volume. While an increase in physical activity or exercise training raises the total blood and plasma volume (29), results from bed deconditioned athletes, and bed rest experiments showed that decrease in physical activity can lead to a reduction in total blood and plasma volume (30). A previous study showed that FFM may account for nearly 80 to 85% of the variance in the directly measured whole blood or plasma volumes, respectively (31). We performed sensitivity analyses showing that most of the variation in liver volume was explained by FFM, which constitutes approximately 50% of skeletal muscle mass (32). Fat free mass is considered the main factor for changes in blood and plasma volumes through its metabolic demands (33). The reduction in blood and plasma volumes will result in a lower volume unload of the liver with a possible consequent dwindling in its size. Moreover, a more sedentary lifestyle may also lead to a slower and gradual reduction in total skeletal muscle mass, further reducing physical activity (34) (Figure 3).

A previous study from our group found that lower cardiorespiratory fitness measured by Vo2peak was associated with higher liver fat content and gamma-glutamyl transferase (GGT) levels, particularly in obese and overweight individuals (21). This finding may be explained by effects of sedentary lifestyle on body fat, which may result in a larger liver fat content, but not necessarily in a larger liver volume. Thus, the results of the present study are not in contrast to our previous study as effects of VO2peak on relative fat content and liver function may differ to those on absolute liver volume. Contrary to this findings, we previously demonstrated that a larger liver volume is associated with a 3-fold higher risk of all-cause mortality. The possible explanation for these different results might be that larger liver volume is often associated with hepatic steatosis and fibrosis, which contribute to metabolic dysfunction and increased mortality risk (35). In contrast, a previous study showed that decreased skeleton muscle mass and strength are associated with poor hepatic function and metabolic health (36). Furthermore, poor physical fitness is associated with reduced blood flow to the liver and muscle-liver crosstalk dysfunction, which might contribute to a smaller liver volume (37).

After standardisation of the VO2peak and handgrip strength values, the VO2peak showed a stronger association with liver volume than handgrip strength . However, it is more difficult to improve the VO2peak by endurance training than to increase handgrip strength by resistance training. Thus, for lifestyle intervention we believe that it may be favourable to increase handgrip strength to prevent a decline in liver volume.

One of the major strengths of our study is that it includes a large number of individuals derived from a population-based study. In addition, liver volume was assessed by using MRI-PDFF, which is the most accurate and sensitive marker to measure liver volume compared to other non-invasive methods such as ultrasound (38). Along with this, we measured VO2peak by a standard method of the cardiopulmonary exercise test.

Limitations of our study include its cross-sectional design. Hence, we cannot draw any causal inference from the observed associations. Second, we included only Caucasian individuals in our analysis; therefore, the generalisability of our results to other ethnic groups might be not appropriate. Finally, although we adjusted our regression models for potential confounding factors, there is still the possibility of unmeasured or unknown potential confounders.

Conclusion

Our results derived from a large community-based sample showed that lower values of VO2peak and handgrip strength are closely associated with a smaller liver volume (as assessed by MRI). These results might explain the possible adverse effects of sedentary lifestyle on liver volume – the sedentary liver.

Acknowledgement

Study of Health in Pomerania (SHIP) is part of the Community Medicine Research Network (CMR) of the University Medicine Greifswald, which is supported by the German Federal State of Mecklenburg-West Pomerania, the Ministry of Cultural Affairs, and the Social Ministry of the Federal State of Mecklenburg–West Pomerania. The CMR encompasses several research projects that are sharing data of the population-based (SHIP; http://ship.community-medicine.de).

Disclosure statement

There is no conflict of interest.

Funding

This research work was funded in part by grants from the German Federal Ministry for Education and Research, from the Ministry for Education, Research and Cultural Affairs, the Ministry for Social Affairs of the State Mecklenburg-West Pomerania.

Notes on contributors

Muhammad Naeem: data analysis, manuscript writing; Marcello Ricardo Paulista Markus: manuscript drafting; Mohammed Mousa: manuscript drafting; Sabine Schipf: manuscript drafting; Markus Doerr: design of the study, manuscript drafting; Antje Steveling: design of the study, manuscript drafting; Jens-Peter Kühn: design of the study, manuscript drafting; Marie-Luise Kromrey: design of the study, manuscript drafting; Matthias Nauck: design of the study, manuscript drafting; Giovanni Targher: manuscript drafting; Henry Völzke: design of the study, manuscript writing; Till Ittermann: data analysis, manuscript writing.

ORCID

Muhammad Naeem https://orcid.org/0000-0001-8455-6599

Beate Stubbe https://orcid.org/0000-0002-7571-744X

Ralf Ewert https://orcid.org/0000-0002-6746-9925

Robin Bülow https://orcid.org/0000-0003-1884-5784

Martin Bahls https://orcid.org/0000-0002-2016-5852

Marcus Doer https://orcid.org/0000-0001-7471-475X

Ali Aghdassi https://orcid.org/0000-0002-0569-7316

Giovanni Targher https://orcid.org/0000-0002-4325-3900

Henry Völzke https://orcid.org/0000-0001-7003-399X

Marcello RP Markus https://orcid.org/0000-0002-6234-4955

Till Ittermann https://orcid.org/0000-0002-0154-7353

References

  • 1.Davidson T, Vainshelboim B, Kokkinos P, Myers J, Ross R. Cardiorespiratory fitness versus physical activity as predictors of all-cause mortality in men. Am Heart J 2018;196:156–62. 10.1016/j.ahj.2017.08.022 [DOI] [PubMed] [Google Scholar]
  • 2.Kondamudi N, Mehta A, Thangada ND, Pandey A. Physical activity and cardiorespiratory fitness: vital signs for cardiovascular risk assessment. Curr Cardiol Rep 2021;23:172. 10.1007/s11886-021-01596-y [DOI] [PubMed] [Google Scholar]
  • 3.Ross R, Blair SN, Arena R, Church TS, Després J-P, Franklin BA, et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation 2016;134:e653–99. 10.1161/CIR.0000000000000461 [DOI] [PubMed] [Google Scholar]
  • 4.de Lima TR, Martins PC, Moreno YMF, Chaput J-P, Tremblay MS, Sui X, et al. Muscular fitness and cardiometabolic variables in children and adolescents: a systematic review. Sports Med. 2022;52:1555–75. 10.1007/s40279-021-01631-6 [DOI] [PubMed] [Google Scholar]
  • 5.Kaminsky LA, Arena R, Ellingsen Ø, Harber MP, Myers J, Ozemek C, et al. Cardiorespiratory fitness and cardiovascular disease – the past, present, and future. Progr Cardiovasc Dis 2019;62:86–93. 10.1016/j.pcad.2019.01.002 [DOI] [PubMed] [Google Scholar]
  • 6.Tarp J, Stole AP, Blond K, Grontved A. Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetologia 2019;62:1129–42. 10.1007/s00125-019-4867-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise for muscular strength in older adults: a meta-analysis. Age Res Rev 2010;9:226–37. 10.1016/j.arr.2010.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.McGrath RP, Kraemer WJ, Snih SA, Peterson MD. Handgrip strength and health in aging adults. Sports Med 2018;48:1993–2000. 10.1007/s40279-018-0952-y [DOI] [PubMed] [Google Scholar]
  • 9.Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci 2012;67:28–40. 10.1093/gerona/glr010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Laukkanen JA, Kurl S, Salonen R, Rauramaa R, Salonen JT. The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study. Eur Heart J 2004;25:1428–37. 10.1016/j.ehj.2004.06.013 [DOI] [PubMed] [Google Scholar]
  • 11.Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet 2015;386:266–73. 10.1016/S0140-6736(14)62000-6 [DOI] [PubMed] [Google Scholar]
  • 12.Gal DL, Santos AC, Barros H. Leisure-time versus full-day energy expenditure: a cross-sectional study of sedentarism in a Portuguese urban population. BMC Public Health 2005;5:16. 10.1186/1471-2458-5-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Dunn MA, Kappus MR, Bloomer PM, Duarte-Rojo A, Josbeno DA, Jakicic JM. Wearables, physical activity, and exercise testing in liver disease. Semin Liver Dis 2021;41:128–35. 10.1055/s-0040-1716564 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Baker CJ, Martinez-Huenchullan SF, D’Souza M, Xu Y, Li M, Bi Y, et al. Effect of exercise on hepatic steatosis: are benefits seen without dietary intervention? A systematic review and meta-analysis. J Diabetes 2021;13:63–77. 10.1111/1753-0407.13086 [DOI] [PubMed] [Google Scholar]
  • 15.López-Gil JF, Ramírez-Vélez R, Alarcón-Jiménez J, Izquierdo M, García-Hermoso A. Low handgrip strength is associated with higher liver enzyme concentrations in US adolescents. Pediatr Res 2021;91:984–90. 10.1038/s41390-021-01530-6 [DOI] [PubMed] [Google Scholar]
  • 16.Markus MRP, Ittermann T, Drzyzga CJ, Bahls M, Schipf S, Siewert-Markus U, et al. Lower cardiorespiratory fitness is associated with a smaller and stiffer heart: the Sedentary’s heart. JACC Cardiovasc Imaging 2021;14:310–3. 10.1016/j.jcmg.2020.07.032 [DOI] [PubMed] [Google Scholar]
  • 17.Markus MRP, Ittermann T, Drzyzga CJ, Bahls M, Schipf S, Siewert-Markus U, et al. Cardiac MRI shows an association of lower cardiorespiratory fitness with decreased myocardial mass and higher cardiac stiffness in the general population – the Sedentary’s Heart. Progr Cardiovasc Dis 2021;68:25–35. 10.1016/j.pcad.2021.09.003 [DOI] [PubMed] [Google Scholar]
  • 18.Markus MRP, Ittermann T, Kim S, Schipf S, Siewert-Markus U, Santana CC, et al. Lower muscular strength is associated with smaller left and right chambers and lower cardiac mass in the general population – the Sedentary’s Heart. Progr Cardiovasc Dis 2021;68:36–51. 10.1016/j.pcad.2021.09.004 [DOI] [PubMed] [Google Scholar]
  • 19.Drzyzga CJ, Bahls M, Ittermann T, Völzke H, Bülow R, Hammer F, et al. Lower cardiorespiratory fitness is associated with right ventricular geometry and function – the Sedentary’s Heart: SHIP. J Am Heart Assoc 2021;10:e021116. 10.1161/JAHA.120.021116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zinterl I, Ittermann T. Low cardiopulmonary fitness is associated with higher liver fat content and higher gamma-glutamyltransferase concentrations in the general population – “The Sedentary’s Liver”. Liver Int 2022;42:585–94. 10.1111/liv.15162 [DOI] [PubMed] [Google Scholar]
  • 21.Lee S-B, Kwon Y-J, Jung D-H, Kim J-K. Association of muscle strength with non-alcoholic fatty liver disease in Korean adults. Int J Environ Res Public Health 2022;19:1675. 10.3390/ijerph19031675 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Naeem M, Markus MRP, Mousa M, Schipf S, Dörr M, Steveling A, et al. Associations of liver volume and other markers of hepatic steatosis with all-cause mortality in the general population. Liver Int 2022;42:575–84. 10.1111/liv.15133 [DOI] [PubMed] [Google Scholar]
  • 23.Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011;40:294–307. 10.1093/ije/dyp394 [DOI] [PubMed] [Google Scholar]
  • 24.Gläser S, Koch B, Ittermann T, Christoph S, Marcus D, Felix SB, et al. Influence of age, sex, body size, smoking, and beta blockade on key gas exchange exercise parameters in an adult population. Eur J Cardiovasc Prev Rehabil 2010;17:469–76. 10.1097/HJR.0b013e328336a124 [DOI] [PubMed] [Google Scholar]
  • 25.Köhler A, King R, Bahls M, Groß S, Steveling A, Gärtner S, et al. Cardiopulmonary fitness is strongly associated with body cell mass and fat-free mass: the Study of Health in Pomerania (SHIP). Scand J Med Sci Sports 2018;28:1628–35. 10.1111/sms.13057 [DOI] [PubMed] [Google Scholar]
  • 26.Kuhn JP, Hernando D, Munoz del Rio A, Evert M, Kannengiesser S, Volzke H, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology 2012;265:133–42. 10.1148/radiol.12112520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kromrey ML, Ittermann T, vWahsen C, Plodeck V, Seppelt D, Hoffmann RT, et al. Reference values of liver volume in Caucasian population and factors influencing liver size. Eur J Radiol 2018;106:32–37. 10.1016/j.ejrad.2018.07.005 [DOI] [PubMed] [Google Scholar]
  • 28.Warburton DE, Haykowsky MJ, Quinney HA, Blackmore D, Teo KK, Taylor DA, et al. Blood volume expansion and cardiorespiratory function: effects of training modality. Med Sci Sports Exerc 2004;36:991–1000. 10.1249/01.MSS.0000128163.88298.CB [DOI] [PubMed] [Google Scholar]
  • 29.Convertino VA. Blood volume response to physical activity and inactivity. Am J Med Sci 2007;334:72–9. 10.1097/MAJ.0b013e318063c6e4 [DOI] [PubMed] [Google Scholar]
  • 30.Sawka MN, Young AJ, Pandolf KB, Dennis RC, Valeri CR. Erythrocyte, plasma, and blood volume of healthy young men. Med Sci Sports Exerc 1992;24:447–53. 10.1249/00005768-199204000-00009 [DOI] [PubMed] [Google Scholar]
  • 31.Wang Z, Deurenberg P, Wang W, Pietrobelli A, Baumgartner RN, Heymsfield SB. Hydration of fat-free body mass: review and critique of a classic body-composition constant. Am J Clin Nutr 1999;69:833–41. 10.1093/ajcn/69.5.833 [DOI] [PubMed] [Google Scholar]
  • 32.Markus MR, Stritzke J, Siewert U, Lieb W, Luchner A, Döring A, et al. Variation in body composition determines long-term blood pressure changes in pre-hypertension: the MONICA/KORA (Monitoring Trends and Determinants on Cardiovascular Diseases/Cooperative Research in the Region of Augsburg) cohort study. J Am Coll Cardiol 2010;56:65–76. 10.1016/j.jacc.2010.01.056 [DOI] [PubMed] [Google Scholar]
  • 33.Kyle UG, Genton L, Gremion G, Slosman DO, Pichard C. Aging, physical activity and height-normalized body composition parameters. Clin Nutr 2004;23:79–88. 10.1016/S0261-5614(03)00092-X [DOI] [PubMed] [Google Scholar]
  • 34.Ekstedt M, Nasr P, Kechagias S. Natural history of NAFLD/NASH. Curr Hepatol Rep 2017;16:391–7. 10.1007/s11901-017-0378-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kim G, Kim JH. Impact of skeletal muscle mass on metabolic health. Endocrinol Metab (Seoul) 2020;35:1–6. 10.3803/EnM.2020.35.1.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The effects of physical exercise on fatty liver disease. Gene Expr 2018;18:89–101. 10.3727/105221617X15124844266408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Seppelt D, Ittermann T, Kromrey ML, Kolb C, vWahsen C, Heiss P, et al. Simple diameter measurement as predictor of liver volume and liver parenchymal disease. Sci Rep 2022;12:1257. 10.1038/s41598-022-04825-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Upsala Journal of Medical Sciences are provided here courtesy of Upsala Medical Society

RESOURCES